Now a Virtual Experience: 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference
Vision for Biomanufacturing: Today's Challenges and Tomorrow's Therapies
We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital: The 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference.
You will still:
Hear compelling and informative presentations from global experts representing regulatory, industry, and academia
Refine your own expertise and gain new insights into critical trends in the bio sector, including cell and gene therapy, monoclonal antibodies, oligonucleotides, and personalized medicines.
Explore the case studies in process development and equipment design for profitable and sustainable manufacturing
Learn about innovations in facility design and operations, and strategies for collaboration between manufacturers and regulators
See how you can implement best practices used by CDMOs in non-traditional biopharma processes
Understand the supply chain risks and challenges associated with the production of personalized medicines
It's our priority to make this the best and most informative ISPE Biopharmaceutical Manufacturing Conference to date, and we remain excited to host you in June. We will update the event page in the coming weeks with additional information.
Who Should Attend
Emerging Technologies Scientists and Professionals
Bio Site Directors and above
Manufacturing, Quality Control and Quality Assurance heads
Engineering and Facility management heads
Contract Manufacturing interface heads
Key supply chain interfaces
Process sciences, process development heads
Global Regulatory Authorities involved in BLA, PAI, New Technologies
Construction services, engineering services
Suppliers (resins, media, etc.)
All levels of experience will benefit from the presentations and opportunities for engagement to continue to shape the direction of the pharmaceutical industry